For carriers of P/LP variants in BRCA1/2 genes, all guidelines recommend incorporating breast magnetic resonance imaging (MRI) into IBS, typically starting between ages 25–30, with mammography added at 30–40 years. The gene discussed is BRCA1; the disease is irritable bowel syndrome.